Citazione APA

Arvaniti, P., Giannoulis, G., Gabeta, S., Zachou, K., Koukoulis, G. K., & Dalekos, G. N. (2020). Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis. JHEP Rep.

Stile di citazione Chicago

Arvaniti, Pinelopi, George Giannoulis, Stella Gabeta, Kalliopi Zachou, George K. Koukoulis, e George N. Dalekos. "Belimumab Is a Promising Third-line Treatment Option for Refractory Autoimmune Hepatitis." JHEP Rep 2020.

Citazione MLA

Arvaniti, Pinelopi, et al. "Belimumab Is a Promising Third-line Treatment Option for Refractory Autoimmune Hepatitis." JHEP Rep 2020.

Attenzione: Queste citazioni potrebbero non essere precise al 100%.